Briefing
Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer
Personalized ctDNA dynamics were associated with survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer.
- Design: Evidence level 3
- Assay: Not named in the abstract
NPJ Precis OncolPubMed 40846896DOI 10.1038/s41698-025-01084-4